share_log

药康生物(688046.SH):青岛国药拟减持不超过1.5%股份

Yaokang Biotechnology (688046.SH): Qingdao National Medicine plans to reduce its shareholding by no more than 1.5%.

Gelonghui Finance ·  Jun 7 04:27

PharmaKang Biological (688046.SH) announced on June 7 that, due to its own funding needs, Qingdao Guoyao intends to reduce its shareholding in the company through block trading, with a total reduction of no more than 6,150,000 shares, or 1.50% of the total share capital of the company. The reduction will be carried out within three months after 15 trading days from the date of this announcement.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment